KalVista Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
KalVista Pharmaceuticals, Inc. has filed 884 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 201-225 of 882 matching filings.

Per page
25
Current page
9
424B5 File 333-280759

424B5

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88797

SC 13G/A filing

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Oct 2024
Reporting date
03 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Oct 2024
Reporting date
03 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Oct 2024
Reporting date
03 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Oct 2024
Reporting date
03 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Oct 2024
Reporting date
03 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Sep 2024
Reporting date
09 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
11 Sep 2024
Reporting date
09 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Sep 2024
Reporting date
06 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Aug 2024
Reporting date
22 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Aug 2024
Reporting date
22 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36830

ARS

Filing date
22 Aug 2024
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36830

DEFA14A

Filing date
22 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36830

DEF 14A

Filing date
22 Aug 2024
Reporting date
03 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Aug 2024
Reporting date
17 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Aug 2024
Reporting date
17 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Aug 2024
Reporting date
17 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-280759

EFFECT filing

Filing date
19 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .